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Identity 
Other names: CSBP; FLJ41122; HNRPK; TUNP 
HGNC (Hugo): HNRNPK 
Location: 9q21.32 
Note 
The heterogeneous nuclear ribonucleoproteins 
(hnRNPs) are a family of proteins that play 
fundamental roles in a variety of biological processes 
including cellular signaling, telomere elongation, DNA 
repair and the regulation of expression at both the 
transcriptional and trans-lational levels. Among these 
proteins hnRNPK (K protein) is one the of the most 
extensively studied. The ribonucleoprotein K orthologs 
were described in yeasts, fruit fly and worm (Bomsztyk 
et al., 2004). 
DNA/RNA 
Description 
The hnRNPK gene contains 17 exons spanning 12572 
bp. 
Transcription 
Three alternatively spliced human hnRNPK trans-cripts 
are known. Both variant 1 (2995 bp) and variant 2 
(2960 bp) encode a 464aa long isoform A  
and the variant 3 (2935 bp) product is the 463aa 
isoform B. The amino acid sequence at the C-terminus 
of the isoform A differs from the isoform B as follows: 
459-463aa: (A)ADVEGF --> (B)SGKFF. 
Pseudogene 
At least three hnRNPK human pseudogenes have been 




The hnRNPK protein (65kDa) is structurally related to 
four other poly(C)-binding proteins (PCBP) which 
contain three K homology (KH) domains that enable 
RNA and DNA binding with a high affinity towards 
polycytosine tracts. The KH domain is about 70 amino 
acids in length and is found in a variety of proteins 
from archaea through higher eukaryotes. hnRNPK also 
carries a nuclear localisation signal (NLS) and a 
nuclear shuttling domain (KNS) together which allow it 
to trans-locate between the cytoplasm and nucleus. It 
also contains a segment called the K protein interactive 
(KI) region, located between the KH2 and KH3 
domain, which has an intrinsically disordered structure. 
This domain is not found in the other  
 
Fig.1 HnRNPK structure. The rectangles represent K homology domains (KH1, 2, 3), the K interactive region (KI), the nuclear localization 
signal (NLS) and the nuclear shuttling domain (KNS). 
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Fig.2 HnRNPK expression patterns in normal and cancer tissues based on human EST sequence abundance derived from the 
GeneHub-GEPIS database. 
 
PCBP proteins and is responsible for many of the 
known hnRNPK protein-protein interactions 
(Bomsztyk et al., 2004). 
Expression 
K protein is an abundant factor. 
Localisation 
Predominantly in the nucleus and cytoplasm; also 
found in mitochondria and plasma membrane. 
Function 
The functions of hnRNPK are defined by its modular 
structure that allows it to interact with both nucleic 
acids and proteins. It has been suggested that hnRNPK 
serves as a docking platform that facilitates the 
interaction between the molecular partners involved in 
the processes that compose gene expression, such as 
transcription and trans-lation regulation, mRNA 
processing and chromatin remodeling (Bomsztyk et al., 
2004). With regard to the factors implicated in the 
process of tumori-genesis, hnRNPK acts as a 
transcription activator for the CT element in the human 
c-myc promoter (Michelotti et al., 1996), the BRCA1 
promoter (Thakur et al., 2003) and the basal promoter 
of the Eukaryotic translation initiation factor 4E - eIF-
4E (Lynch et al., 2005). In response to DNA damage, 
hnRNPK is transiently recruited to the promoters of 
p53-responsive genes (p21) where it acts as a cofactor 
of TP53 protein and is required for triggering 
transcriptional activation (Moumen et al., 2005). A 
recent study identified K protein as a regulator of 
androgen receptor (AR) expression levels; it represses 
AR expression and androgen-induced prostate cancer 
cell growth through trans-lational regulation of AR 
mRNA (Mukhopadhyay et al., 2009). In a loss-of-
function screening system based on intracellular 
expression of single domain antibodies, hnRNPK was 
found as a potential target for cell migration and 
metastasis of human cancerous cells (Inoue et al., 
2007). 
Homology 
Shares homology with four other PCBP proteins which 
contain three KH domains. 
Mutations 
Note 





Expression analysis. A proteomic study on 72 
esophageal squamous cell carcinoma cases and 
adjacent normal tissues in 57 of these cases. 
The study revealed that tumors with nodal metastases 
had a higher amount of hnRNP K than those without 
lymph node metastases. The expres-sion of K protein 
was up-regulated in esophageal cancer tissues 




Expression analysis. A study utilizing a proteomic 
approach to compare the protein expression of normal 
colon epithelium to colorectal cancer tissues. 
The overexpression and cytoplasmatic localization of 
hnRNP K correlated with advancement of colorectal 
cancer. In normal colon K protein was detected only in 
the nucleus whereas in tumour tissues the protein was 
observed both in the cytoplasm and the nucleus 
(Carpenter et al., 2006). 
Lung cancer 
Note 
Expression analysis. An examination of the expression 
of K protein and other hnRNP proteins  
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in lung cancer cell lines and biopsies from 32 lung 
cancer by real time RT-PCR and immunochisto-
chemistry. 
Nuclear expression of hnRNP K in H460 cells 
increased from non-confluent to confluent cultures. In 
confluent cells hnRNP K protein was also found in the 
cytoplasm. 
Up-regulation of hnRNP K was observed in 60% of the 
tumors examined with a higher expression in 
adenocarcinomas (79%) versus squamous cell 
carcinomas (33%). In these cases the localization of the 
protein was mostly nuclear, but half of the positive 




An Immunochistochemical examination of hnRNP K 
and thymidine phosphorylase (TP) expression in 121 
nasopharyngeal carcinoma cases. 
An aberrant cytoplasmic localization of hnRNP K and 
its overexpression was associated with poor survival of 
NPC patients (Chen et al., 2008). 
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